文献速递肾小球疾病

足细胞表达人磷脂酶A2受体1致小鼠发生免疫介导的膜性肾病

Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.
PubMed 文献 · Kidney Int · 2022-09-30

研究构建了足细胞表达全长人PLA2R1的转基因小鼠,该小鼠出生后无肾损害,自3周龄起自发产生抗人PLA2R1抗体、进行性白蛋白尿和高脂血症的肾病综合征及膜性肾病典型形态学表现;而缺乏成熟B、T淋巴细胞的Rag2-/-小鼠则不产生抗体和蛋白尿,表明足细胞表达人PLA2R1可通过抗体介导机制诱导膜性肾病。

要点

  • 足细胞表达人PLA2R1的转基因小鼠出生后无肾损害,自3周龄起自发产生抗人PLA2R1抗体。
  • 该小鼠出现进行性白蛋白尿、高脂血症的肾病综合征及膜性肾病典型形态学表现。
  • 缺乏成熟B、T淋巴细胞的Rag2-/-小鼠不产生抗PLA2R1抗体和蛋白尿。

核心结论

  • 足细胞表达人PLA2R1可在小鼠中诱导以抗体介导为发病基础的膜性肾病。

研究设计与样本

  • 生成足细胞表达全长人PLA2R1的转基因小鼠品系,并观察其出生后肾脏损害及自3周龄起自发产生抗人PLA2R1抗体、肾病综合征和膜性肾病形态学表现。
  • 使用缺乏成熟和功能性B、T淋巴细胞的Rag2-/-小鼠表达人PLA2R1,观察其抗PLA2R1抗体和蛋白尿的发生情况。

主要发现

  • 足细胞表达人PLA2R1的转基因小鼠出生后无肾损害。
  • 该小鼠自3周龄起自发产生抗人PLA2R1抗体、进行性白蛋白尿和高脂血症的肾病综合征。
  • 该小鼠出现膜性肾病典型形态学表现:免疫荧光示肾小球颗粒状鼠IgG沉积,电镜示上皮下电子致密物沉积。
  • 表达人PLA2R1的Rag2-/-小鼠既不产生抗PLA2R1抗体,也不出现蛋白尿。

临床怎么用

  • 该抗体介导模型可用于抗原特异性治疗策略的概念验证评估,例如靶向自身抗体或产生自身抗体的细胞。
  • 该模型可能有助于进一步理解膜性肾病的自身免疫发病机制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antibody-mediated autoimmune pathologies like membranous nephropathy are difficult to model, particularly in the absence of local target antigen expression in model organisms such as mice and rats; as is the case for phospholipase A2 receptor 1 (PLA2R1), the major autoantigen in membranous nephropathy. Here, we generated a transgenic mouse line expressing the full-length human PLA2R1 in podocytes, which has no kidney impairment after birth. Beginning from the age of three weeks, these mice spontaneously developed anti-human PLA2R1 antibodies, a nephrotic syndrome with progressive albuminuria and hyperlipidemia, and the typical morphological signs of membranous nephropathy with granular glomerular deposition of murine IgG in immunofluorescence and subepithelial electron-dense deposits by electron microscopy. Importantly, human PLA2R1-expressing Rag2-/- mice, which lack mature and functioning B and T lymphocytes, developed neither anti-PLA2R1 antibodies nor proteinuria. Thus, our work demonstrates that podocyte expression of human PLA2R1 can induce membranous nephropathy with an underlying antibody-mediated pathogenesis in mice. Importantly, this antibody-mediated model enables proof-of-concept evaluations of antigen-specific treatment strategies, e.g., targeting autoantibodies or autoantibody-producing cells, and may further help understand the autoimmune pathogenesis of membranous nephropathy.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Tomas NM, Dehde S, Meyer-Schwesinger C, et al. Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice. Kidney Int. 2022. PMID: 36191868. doi:10.1016/j.kint.2022.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。